065170 — BL PharmTech Cashflow Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for BL PharmTech, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-20,107	-13,649	142	-5,717	-16,787
Depreciation
Amortisation
Non-Cash Items	21,556	13,080	955	2,372	14,616
Discontinued Operations
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-1,801	-14,052	6,047	-544	1,331
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	3,097	-10,998	7,992	-3,037	-284
Capital Expenditures	-587	-1,708	-312	-1,166	—
Purchase of Fixed Assets
Other Investing Cash Flow Items	909	-1,665	15,606	-5,281	6,657
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Sale of Intangible Assets
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities	322	-3,374	15,294	-6,447	6,657
Financing Cash Flow Items	—	—	—	129	-1,088
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	5,840	-2,322	-17,702	2,738	-3,088
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	9,372	-16,728	5,584	-6,743	3,287